Mergers and acquisitions (M&As), which became extremely common in the branded industry in the 1990s, have recently seen a parallel development in the generics medicines industry. However, generics M&As are more susceptible to impact from cultural barriers. These may become apparent post merger, but can also dramatically affect the success of the negotiations. The reasons for this are discussed and several proposals are made for risk reduction through recognising the importance of the culture differences in play and taking adequate measures to reduce their impact.
KaufmanD.SiegelbaumP. (1997). Privatisation and corruption in transition economies. J. Int. Affairs50(2), 419–458.
5.
KarlinsR. (2002). Typology of post-communist corruption. Probl. Post-Communism48(4), 23–32.
6.
StahlG. K.SitkinS. B. (2004). Trust in mergers and acquisitions, in StahlG.K.MendenhallM. (eds.), Mergers and Acquisitions: Managing culture and human resources, Stanford University Press, Stanford, CA, USA.
7.
DiGeorgioR. M. (2003). Making mergers and acquisitions work: What we know and don't know-Part II. J. Change Manage. 3(3), 259–274.
CartwrightS. (1998). International mergers and acquisitions. The issues and challenges, in GertsenM.C.SoderbergA.M.TorpJ.E. (eds.), Cultural dimensions of international mergers and acquisitions, Walter de Gruyter, Berlin, New York, pp. 5–17.
10.
De SmedtS.TortoriciV.van OckenburgE. (2005). Reducing the risk of early M&A discussions. McKinsey on Finance No. 17, pp. 5–10.
